By assessing the CCL5 level with the NIHSS scale (NIHSS ≤ 3 or >3) at the hospital admission and discharge, we confirmed [15] that in the group of patients with ischemic stroke with a good prognosis, CCL5 levels were lower, and on the seventh day even with p = 0.032 (Table 3). The gene discussed is CCL5; the disease is ischemic stroke.